BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16354586)

  • 1. Activating mutations and/or expression levels of tyrosine kinase receptors GRB7, RAS, and BRAF in testicular germ cell tumors.
    McIntyre A; Summersgill B; Spendlove HE; Huddart R; Houlston R; Shipley J
    Neoplasia; 2005 Dec; 7(12):1047-52. PubMed ID: 16354586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KIT and RAS signalling pathways in testicular germ cell tumours: new data and a review of the literature.
    Goddard NC; McIntyre A; Summersgill B; Gilbert D; Kitazawa S; Shipley J
    Int J Androl; 2007 Aug; 30(4):337-48; discussion 349. PubMed ID: 17573850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant epigenetic inactivation of RASSF1A and MGMT gene and genetic mutations of KRAS, cKIT and BRAF in Indian testicular germ cell tumours.
    Ahmad F; Surve P; Natarajan S; Patil A; Pol S; Patole K; Das BR
    Cancer Genet; 2020 Feb; 241():42-50. PubMed ID: 31653608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations of BRAF and RAS are rare events in germ cell tumours.
    Sommerer F; Hengge UR; Markwarth A; Vomschloss S; Stolzenburg JU; Wittekind C; Tannapfel A
    Int J Cancer; 2005 Jan; 113(2):329-35. PubMed ID: 15386408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wilms tumor gene 1 (WT1), TP53, RAS/BRAF and KIT aberrations in testicular germ cell tumors.
    Boublikova L; Bakardjieva-Mihaylova V; Skvarova Kramarzova K; Kuzilkova D; Dobiasova A; Fiser K; Stuchly J; Kotrova M; Buchler T; Dusek P; Grega M; Rosova B; Vernerova Z; Klezl P; Pesl M; Zachoval R; Krolupper M; Kubecova M; Stahalova V; Abrahamova J; Babjuk M; Kodet R; Trka J
    Cancer Lett; 2016 Jul; 376(2):367-76. PubMed ID: 27085458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-RAS and N-RAS mutations in testicular germ cell tumors.
    Hacioglu BM; Kodaz H; Erdogan B; Cinkaya A; Tastekin E; Hacibekiroglu I; Turkmen E; Kostek O; Genc E; Uzunoglu S; Cicin I
    Bosn J Basic Med Sci; 2017 May; 17(2):159-163. PubMed ID: 28426398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic KIT mutations occur predominantly in seminoma germ cell tumors and are not predictive of bilateral disease: report of 220 tumors and review of literature.
    Coffey J; Linger R; Pugh J; Dudakia D; Sokal M; Easton DF; Timothy Bishop D; Stratton M; Huddart R; Rapley EA
    Genes Chromosomes Cancer; 2008 Jan; 47(1):34-42. PubMed ID: 17943970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification and overexpression of the KIT gene is associated with progression in the seminoma subtype of testicular germ cell tumors of adolescents and adults.
    McIntyre A; Summersgill B; Grygalewicz B; Gillis AJ; Stoop J; van Gurp RJ; Dennis N; Fisher C; Huddart R; Cooper C; Clark J; Oosterhuis JW; Looijenga LH; Shipley J
    Cancer Res; 2005 Sep; 65(18):8085-9. PubMed ID: 16166280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of the c-kit gene in testicular germ cell tumors.
    Sakuma Y; Sakurai S; Oguni S; Hironaka M; Saito K
    Cancer Sci; 2003 Jun; 94(6):486-91. PubMed ID: 12824871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma.
    Biermann K; Göke F; Nettersheim D; Eckert D; Zhou H; Kahl P; Gashaw I; Schorle H; Büttner R
    J Pathol; 2007 Nov; 213(3):311-8. PubMed ID: 17768701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.
    Looijenga LH; de Leeuw H; van Oorschot M; van Gurp RJ; Stoop H; Gillis AJ; de Gouveia Brazao CA; Weber RF; Kirkels WJ; van Dijk T; von Lindern M; Valk P; Lajos G; Olah E; Nesland JM; Fosså SD; Oosterhuis JW
    Cancer Res; 2003 Nov; 63(22):7674-8. PubMed ID: 14633689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors.
    Mata DA; Yang SR; Ferguson DC; Liu Y; Sharma R; Benhamida JK; Al-Ahmadie HA; Chakravarty D; Solit DB; Tickoo SK; Gupta S; Arcila ME; Ladanyi M; Feldman DR; Reuter VE; Vanderbilt CM
    Urology; 2020 Oct; 144():111-116. PubMed ID: 32721511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of c-kit gene in bilateral testicular germ cell tumours in Japan.
    Sakuma Y; Matsukuma S; Yoshihara M; Sakurai S; Nishii M; Kishida T; Kubota Y; Nagashima Y; Inayama Y; Sasaki T; Nakamura Y; Miura T; Kameda Y; Tsuchiya E; Miyagi Y
    Cancer Lett; 2008 Jan; 259(1):119-26. PubMed ID: 18006222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of c-kit exons 11- and 17-activating mutations in testicular seminomas by high-resolution melting amplicon analysis.
    Willmore-Payne C; Holden JA; Chadwick BE; Layfield LJ
    Mod Pathol; 2006 Sep; 19(9):1164-9. PubMed ID: 16741525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A c-KIT codon 816 mutation, D816H, in the testicular germ cell tumor: case report of a Japanese patient with bilateral testicular seminomas.
    Tate G; Suzuki T; Kishimoto K; Mitsuya T
    Acta Med Okayama; 2005 Feb; 59(1):33-6. PubMed ID: 15902997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restricted 12p amplification and RAS mutation in human germ cell tumors of the adult testis.
    Roelofs H; Mostert MC; Pompe K; Zafarana G; van Oorschot M; van Gurp RJ; Gillis AJ; Stoop H; Beverloo B; Oosterhuis JW; Bokemeyer C; Looijenga LH
    Am J Pathol; 2000 Oct; 157(4):1155-66. PubMed ID: 11021820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAS/RAF mutation and defective DNA mismatch repair in endometrial cancers.
    Mutch DG; Powell MA; Mallon MA; Goodfellow PJ
    Am J Obstet Gynecol; 2004 Apr; 190(4):935-42. PubMed ID: 15118616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant mutations and splice variants in KRAS and BRAF demonstrate complex perturbation of the Ras/Raf signalling pathway in advanced colorectal cancer.
    Seth R; Crook S; Ibrahem S; Fadhil W; Jackson D; Ilyas M
    Gut; 2009 Sep; 58(9):1234-41. PubMed ID: 19474002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations of BRAF and KRAS2 in the development of Barrett's adenocarcinoma.
    Sommerer F; Vieth M; Markwarth A; Röhrich K; Vomschloss S; May A; Ell C; Stolte M; Hengge UR; Wittekind C; Tannapfel A
    Oncogene; 2004 Jan; 23(2):554-8. PubMed ID: 14724583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A subset of colorectal carcinomas express c-KIT protein independently of BRAF and/or KRAS activation.
    Preto A; Moutinho C; Velho S; Oliveira C; Rebocho AP; Figueiredo J; Soares P; Lopes JM; Seruca R
    Virchows Arch; 2007 Jun; 450(6):619-26. PubMed ID: 17487504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.